Clinical and R&D support

Client global
surveys show
a shortfall in
necessary
digital
engagement

Clinical and R&D stakeholders need increased engagement leading to greater understanding, motivation and correct use of your product. Understanding and working effectively with patients is now at the heart of drug development. We have the technical, strategic, and creative skill to build the two-way link between protocol and patient.Clinical and R&D stakeholders need increased engagement leading to greater understanding, motivation and correct use of your product. Understanding and working effectively with patients is now at the heart of drug development.

We have the technical, strategic, and creative skill to build the two-way link between protocol and patient.We deliver dynamic strategy and programmes to support Clinical Trial communications, digital engagement, Investigator meetings, CT Identity/Branding/Comms, internal and external publication/communication planning and delivery.

Portfolio/Program Identity creation

Creating an identity for a clinical development program/portfolio is a key strategy for:

• creating awareness and improve understanding with target audiences

• unifying studies within a common identity

• achieving greater engagement from investigators

• enabling alignment and motivation for both internal and external stakeholders.

Investigator support

Novel web-based, community programmes to support your multi- centre trials and registries and build your advocacy leaders.

Patient adherenceMass has developed patient adherence programmes for a number of orphan drugs  which have seen good success in overcoming barriers to adherence. These programmes combine patient education and adherence support tools with a personalised nurse support service. This multi- disciplinary approach helps empower patients with the knowledge of why they should stick to their prescribed treatment course at the right dosage, and the belief in their ability to take control of their health.

Enhanced patient adherence is good news all round, as optimal patient outcomes, improved physician-patient communication and more cost-effective care benefits both patients and clinicians, as well as fostering brand familiarisation for your product.

Back
Projects
Contact


“We organise into dynamic teams applying skills required to achieve results across both individual projects”

David Goodman, Managing Director

Contact
Portfolio

 

 

 

 


The digital challenge

The challenge is delivering on the evolved expectations of HCPs, their patients and all stakeholders. Successful digital engagement can be hard to achieve and yet is the minimum requirement for multiple stakeholders.

More
Portfolio
Contact